How should I wean a hemodynamically stable adult on mechanical ventilation who is on minimal vasopressor support, has adequate oxygenation with FiO2 (fraction of inspired oxygen) ≤0.40, PEEP (positive end‑expiratory pressure) ≤5 cm H2O (PaO2/FiO2 >200 mm Hg), is normothermic, awake, able to protect his airway, and can initiate spontaneous breaths?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weaning from Mechanical Ventilation

For this hemodynamically stable adult meeting readiness criteria, perform a spontaneous breathing trial using pressure support ventilation at 5-8 cm H₂O with PEEP 5 cm H₂O for 30 minutes, then extubate directly to supplemental oxygen targeting SpO₂ 88-92% if the trial is successful. 1, 2

Daily Readiness Assessment

Before initiating any weaning attempt, confirm the patient meets all of the following criteria:

  • Resolution or significant improvement of the primary condition requiring mechanical ventilation 1, 2
  • Hemodynamic stability without vasopressor support (your patient meets this with minimal vasopressor support, which should be discontinued or weaned to zero before proceeding) 1, 2
  • Adequate oxygenation: FiO₂ ≤0.40-0.50, PEEP ≤5 cm H₂O, PaO₂/FiO₂ >200 mm Hg 1, 2
  • Patient arousable and able to follow simple commands (open eyes, squeeze hand) 2, 3
  • Intact airway reflexes with adequate cough on suctioning 1, 2
  • No new potentially serious conditions or planned procedures in the next 12-24 hours 4, 1

Critical pitfall: Do not attempt weaning if the patient still requires vasopressor support beyond minimal doses—hemodynamic stability is mandatory. 2

Conducting the Spontaneous Breathing Trial

Optimal SBT Technique

Use pressure support ventilation at 5-8 cm H₂O with PEEP 5 cm H₂O rather than a T-piece for the initial trial. This approach achieves superior outcomes: 1, 2

  • SBT success rate: 84.6% vs. 76.7% with T-piece 1, 2
  • Extubation success rate: 75.4% vs. 68.9% with T-piece 1, 2
  • Trend toward lower ICU mortality: 8.6% vs. 11.6% 2

SBT Parameters

  • Duration: 30 minutes for standard-risk patients (most failures occur within this timeframe) 1, 2, 3
  • FiO₂: Maintain at ≤0.40 during the trial 1, 2
  • PEEP: Set at 5 cm H₂O 1, 2

SBT Failure Criteria—Terminate Immediately If:

  • Respiratory rate >35 breaths/min or increasing trend 2
  • SpO₂ <90% 1, 2
  • Heart rate >140 bpm or sustained increase >20% 2
  • Blood pressure: Systolic >180 mmHg or <90 mmHg 2
  • Increased anxiety or diaphoresis 1, 2
  • Use of accessory muscles or abdominal paradox 2
  • Altered mental status 1, 3

Risk Stratification for Extubation

Your patient appears to be standard-risk based on the clinical description. However, verify the absence of high-risk features:

High-Risk Criteria (if ANY present, modify post-extubation strategy):

  • Age >65 years with multiple comorbidities 1, 2
  • Cardiac failure as primary cause of respiratory failure 1, 2
  • Failure of more than one prior SBT 1, 2
  • Weak cough or excessive secretions 2, 3
  • Chronic lung disease (COPD, restrictive disease) 1, 3
  • Prolonged mechanical ventilation >14 days 1, 3

Extubation Strategy

For Standard-Risk Patients (Your Patient):

Extubate directly to supplemental oxygen via face mask or nasal cannula, targeting SpO₂ 88-92%. 2

  • Monitor SpO₂, respiratory rate, and work of breathing continuously for the first 24 hours 2
  • No prophylactic NIV is required for standard-risk patients 2

For High-Risk Patients (If Applicable):

Apply prophylactic noninvasive ventilation (NIV) within 1 hour after extubation rather than standard oxygen therapy. This approach reduces: 1, 2

  • Re-intubation risk (RR 0.61; 95% CI 0.48-0.79) 2
  • Mortality (RR 0.54; 95% CI 0.41-0.70) 2
  • ICU length of stay by approximately 2.5 days 2

Alternative for high-risk patients: High-flow nasal cannula (HFNC) lowers re-intubation rates to 4% vs. 21% with conventional oxygen (P=0.01). 2

Protocol-Driven Implementation

Use a standardized weaning protocol led by respiratory therapists or ICU nurses, with physician sign-off only for the final extubation decision. This approach: 2

  • Reduces total mechanical ventilation duration by approximately 25 hours 2
  • Shortens ICU length of stay by approximately 1 day 2
  • Increases overall weaning success rates 2

Common Pitfalls to Avoid

  • Do not delay extubation in patients who pass their first SBT and lack high-risk features—unnecessary delays increase complications 2
  • Avoid premature weaning if vasopressor support has not been discontinued or if the primary pathology remains unresolved 2
  • Do not skip the cuff-leak test in patients with risk factors for laryngeal edema (female gender, nasal intubation, difficult intubation, prolonged intubation) as post-extubation stridor accounts for 15% of early re-intubations 2
  • Monitor closely for the first 24 hours—approximately 10% of patients who pass an SBT will still fail extubation, which is considered an acceptable rate 2

Expected Outcomes

  • Extubation success is defined as not requiring re-intubation or NIV within the first 48 hours post-extubation 2
  • An extubation failure rate of 5-10% is considered acceptable in contemporary practice 2
  • With the pressure-support SBT approach, expect approximately 75% extubation success in standard-risk patients 1, 2

References

Guideline

Spontaneous Breathing Trials in Mechanically Ventilated Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Weaning from Mechanical Ventilation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ventilator Sedation and Weaning Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.